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Improved understanding of abdominal aortic aneurysms (AAA) pathogenesis is required to
identify treatment targets. This systematic review summarized evidence from animal
studies and clinical research examining the role of adipokines and perivascular adipose
tissue (PVAT) in AAA pathogenesis. Meta-analyses suggested that leptin (Standardized
mean difference [SMD]: 0.50 [95% confidence interval (CI): −1.62, 2.61]) and adiponectin
(SMD: −3.16 [95% CI: −7.59, 1.28]) upregulation did not significantly affect AAA severity
within animal models. There were inconsistent findings and limited studies investigating
the effect of resistin-like molecule-beta (RELMb) and PVAT in animal models of AAA.
Clinical studies suggested that circulating leptin (SMD: 0.32 [95% CI: 0.19, 0.45]) and
resistin (SMD: 0.63 [95% CI 0.50, 0.76]) concentrations and PVAT to abdominal adipose
tissue ratio (SMD: 0.56 [95% CI 0.33, 0.79]) were significantly greater in people diagnosed
with AAA compared to controls. Serum adiponectin levels were not associated with AAA
diagnosis (SMD: −0.62 [95% CI −1.76, 0.52]). One, eight, and one animal studies and
two, two, and four human studies had low, moderate, and high risk-of-bias respectively.
These findings suggest that AAA is associated with higher circulating concentrations of
leptin and resistin and greater amounts of PVAT than controls but whether this plays a role
in aneurysm pathogenesis is unclear.
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Screening studies suggest that abdominal aortic aneurysms (AAA) prevalence is approximately 3%
in men and 1% in women aged over 65 years (1). The main complication of AAA is aortic rupture
which is estimated to cause 200,000 deaths worldwide each year (2). Currently the management of
AAA is limited to surgical repair (3). Randomized clinical trials have demonstrated that early
elective surgical repair does not reduce mortality for people with small asymptomatic AAAs (4, 5).n.org March 2021 | Volume 12 | Article 6184341
Thanigaimani and Golledge Adiposity and Abdominal Aortic AneurysmCurrent guidelines therefore recommend simply monitoring
small (<50mm in women and <55m in men) asymptomatic
AAAs (6). Most small AAAs continue to expand and eventually
reach a diameter when surgical treatment is indicated (6). Drug
therapies which limit growth of small AAAs would be valuable in
clinical practice. Previous small randomized controlled trials
have however failed to identify any effective medications (7).
Adipocytes are fat depots that store excess energy as
triglycerides. They also have an endocrine function by
secreting adipokines, such as leptin, adiponectin, dipeptidyl
peptidase-4 (DPP-4), resistin and resistin-like molecule beta
(RELMb) (8). Leptin is an adipokine involved in regulating
energy homeostasis and obesity. It is considered an important
regulator of b cell mass and survival (9). In patients with leptin
deficiency, recombinant leptin replacement therapy suppresses
appetite and increases energy expenditure and leptin has been
developed as a treatment for obesity (10). The adipokine
adiponectin has insulin-sensitizing, anti-inflammatory and
anti-apoptotic effects (11). Adiponectin and agonists of its
receptor have also been suggested as a treatment for obesity
and its complications (12). DPP4 release has been shown to
strongly correlate with adipocyte size, potentially representing an
important source of DPP4 in obesity (13). Resistin belongs to an
RELM family and is believed to be an important link between
obesity, insulin resistance, and diabetes (14). Increasing evidence
suggests that resistin plays an important role in a variety of
biological processes involved in cardiovascular diseases,
autoimmune disease, and asthma (14). RELM-b is another
member of RELM family that is mainly secreted from the
adipose tissue in rodents (15) and from adipose-associated
macrophages in humans (16). Adipose is deposited over
multiple subcutaneous and visceral sites but when considering
a role in aortic pathology, perivascular aortic adipose tissue
(PVAT) is of particular interest. Adipose tissue residing in the
vascular adventitia has been proposed to act like endocrine cells
that respond to inflammatory stimuli by releasing adipokines
and other signaling mediators to maintain vascular homeostasis
and potentially play a role in aortic pathology (17, 18). This
review summarizes published animal and human studies that
investigated the role of these adipokines and PVAT in
AAA pathogenesis.METHODS
Identification and Inclusion of Studies in
This Review
Studies were identified from the PubMed database published
until 5th August 2020 using the following search terms
[“adiposity” OR “adipose tissue” OR “adipokines” OR
“adiponectin” OR “leptin” OR “resistin” OR “subcutaneous fat”
OR “visceral fat” OR “peri aortic fat” OR “obesity”] AND
[“Abdominal aortic aneurysm” OR “aortic occlusive disease”
OR “aortic rupture”]. Animal and observational human studies
that investigated the role of adipokines or PVAT in AAA were
included. Outcomes included aortic diameter and adipokineFrontiers in Endocrinology | www.frontiersin.org 2concentrations or relative amount. Included articles were
identified by one author (ST) and reviewed by another author
(JG). A minimum of two studies reporting the aortic diameter in
animal studies and adipokines levels or PVAT in human studies
were required for meta-analyses to be performed. In studies
where the effect of deficiency and inhibition of a specific
adipokine or PVAT were reported, data were converted to an
equivalent format in order to include in the same meta-analyses.
Meta-analysis findings were presented as standardized mean
difference (SMD) and 95% confidence intervals (CI). Meta-
analyses were performed using random effects model and an
inverse variance method was used to estimate the heterogeneity
between studies. All analyses were conducted using the “meta”
package of R software version 3.4.4. p value of ≤0.05 were
considered significant.
The quality of the animal studies was assessed using a
modified version of the Animal Research: Reporting of In Vivo
Experiments (ARRIVE) guideline criteria. The quality of the
included human studies was assessed using the modified version
of Newcastle-Ottawa Scale 10 which assessed the study design,
sample size estimation, age and sex-matching of controls,
whether imaging was performed to measure AAA size, method
of AAA size assessment, adjustment for confounders, and
whether the observers were blinded to group during analysis.
Assessment scores with <50, 50–75, and >75% were considered
to have high, moderate, and low risk of bias respectively.RESULTS AND DISCUSSION
The initial search identified 383 studies. Based on the inclusion
criteria, 321 studies were excluded due to not meeting the entry
criteria. The full text of the remaining 62 studies (19 animal and
43 human) were reviewed of which ultimately 10 animal and 8
human studies were included (Figures 1 and 2).
Animal Studies Investigating the Role of
Adipokines or PVAT in AAA
Ten eligible rodent studies were identified (19–28). These studies
included a total of 319 rodents in which the effects of leptin,
resistin, adiponectin, and PVAT were investigated (19–28).
Detailed information about each study is shown in Table 1.
Animal Studies Investigating the Effect of Leptin
in AAA
Four studies including 159 animals investigated the role of leptin
in AAA pathogenesis within mouse model induced using
Angiotensin-II (Ang-II) infusion (19, 21, 22) or peri-aortic
calcium chloride (CaCl2) application (20) (Table 1A). These
studies used mice with different backgrounds including
Apolipoprotein E (ApoE) (19, 22), combined Na-Cl co-
transporter and interleukin (IL)-18 receptor (20), and low
density lipoprotein receptor (LDL-r) (21) deficient mice. The
role of leptin in AAA pathogenesis was explored through local
peri-aortic application (19, 20), intraperitoneal injection (22),
and gene deficiency (20, 21).March 2021 | Volume 12 | Article 618434
Thanigaimani and Golledge Adiposity and Abdominal Aortic AneurysmPeri-aortic application of leptin was reported to promote a
significant increase in AAA severity (diameter) in the Ang-II
model (19). Leptin also promoted aortic and visceral adipose
macrophage infiltration. A further study reported that
perivascular implantation of white adipose tissue in obese or
lean mice resulted in an increased AAA size over controls in the
CaCl2 model (20). Perivascular implantation of adipose tissue
from leptin deficient mice abolished the increase in AAA
diameter size that was demonstrated when adipose tissue from
leptin sufficient mice was used, suggesting a role of leptin in
adipose tissue induced AAA development (20).
In contrast to the above findings, germline leptin deficiency
has been reported to promote the risk of AAA rupture in obese
mice infused with Ang-II but AAA size was not reported in this
study (21). In keeping with a role of leptin in inhibiting AAA
pathogenesis, intraperitoneal injection of leptin (600 mg/kg daily)
has been reported to reduce AAA diameter and risk of rupture in
the Ang-II model (22). Leptin was reported to downregulate
expression of the Th2 cytokine IL-4 and mRNA levels of GATA
binding protein-3 (GATA-3), a key transcription factor for Th2
polarization. In addition, leptin also upregulated Th1 cytokine
interferon-gamma (INF-g) and T-box binding transcription
factor (T-bet), a key transcription factor for Th1 polarization
(22). These results led the authors to suggest that leptin could be
a potential treatment for the prevention of AAA formation.
A meta-analysis of three eligible studies suggested that leptin
upregulation had no significant effect on AAA diameter (SMD:
0.50 [95% CI: −1.62, 2.61]) (Figure 3). Overall the findings ofFrontiers in Endocrinology | www.frontiersin.org 3these studies suggest that the effect of leptin depends on the
method and site of up and downregulation. All four studies used
the same mouse strain (C57BL/6) and experimental period but
the method of leptin upregulation varied markedly which likely
was the cause of the inconsistent findings. The studies reported
that leptin promoted IL18 binding to inflammatory and vascular
cells by upregulating the expression of IL18, the IL18-receptor,
and the Na-Cl co-transporter in addition to augmenting MMP-9
synthesis (19, 20, 22).
Animal Studies Investigating the Effect of
Adiponectin on AAA
Two studies including 64 animals investigated the effect of
adiponectin on AAA development in mouse models (23, 24)
(Table 1B). In high-fat fed mice with LDL-r deficiency,
intravenous injection of a recombinant adenoviral vector
encoding adiponectin was reported to inhibit AAA
development in the Ang-II infusion model (23). Adiponectin
was reported to inhibit AAA development by suppressing aortic
inflammatory cell infiltration, medial degeneration, and elastin
fragmentation (23). Adiponectin was also shown to inhibit the
angiotensin type-1 receptor (AT1R), downregulate expression of
inflammatory cytokines, mast cell protease, and adipose
inflammation, and upregulate lysyl oxidase (LOX) expression
in the aortic wall (23). In keeping with this, germline deletion of
adiponectin has been reported to promote AAA development in
the Ang-II infusion model (24). Adiponectin-deficiency
augmented the early infiltration of macrophages and increasedFIGURE 2 | PRISMA flow diagram illustrating the process of selection of the human studies.FIGURE 1 | PRISMA flow diagram illustrating the process of selection of the animal studies.March 2021 | Volume 12 | Article 618434
TABLE 1 | Animal studies investigating the role of adipokines and PVAT in AAA.
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A) Animal studies investigating the effect of leptin on aortic diameter
(19)
C57BL/6J mice Peri-aortic leptin
application
Ang-II Placebo 16 28 days 1.5 ± 0.1 Para-visceral aortic leptin in ApoE
augments angiotensin II-inducedLeptin + Ang-II 16 1.8 ± 0.2
(21)
C57BL/6J mice Germline deficiency in
leptin
Ang-II Control 10 28 days NR Leptin deficient obese mice exh





C57BL/6J mice Diet induced obesity CaCl2 ApoE−/− no WAT control 9 28 days 0.1 ± 0.03 Perivascular implantation of adi
lean mice exacerbated AAA de
obese mice.
ApoE−/− obese WAT 7 1.1 ± 0.5
ApoE−/− lean WAT 9 2.1 ± 0.9
ApoE−/− Ncc−/− IL18r−/−
obese WAT
8 0.6 ± 0.3
(22)
C57BL/6J mice I.P. injection Ang-II Sham + Saline 8 28 days 1.0 ± 0.2 Pre-treatment with leptin signific
cytokine IL-4 and mRNA levels
polarization, and significantly up
transcription factor for Th1 pola
Ang-II control 12 2.3 ± 0.6
Ang-II + leptin 12 1.5 ± 0.4






Ang-II PBS-infused control (LDLr
−/−)
8 56 days 0.51 ± 0.05 APN inhibited the angiotensin ty
mast cell protease expression,
improved systemic cytokine pro
preventing AAA
AdAPN mice (LDLr−/−) 8 0.53 ± 0.12
AdGFP mice (LDLr−/−) 12 0.88 ± 0.45
(24)
C57BL/6J mice Adiponectin gene
deficiency
Ang-II Control AAA 18 28 days 1.67 ± 0.09 Adiponectin-deficiency augmen
increased the expression of pro
contributing to the elevated inci
APN−/− AAA 18 2.12 ± 0.07
C) Animal studies investigating the effect of Resistin-like molecule-beta on aortic diameter
(25)
ApoE−/− mice Deletion of RELMb Ang-II AAA only 15 28 days 1.0 ± 0.1 Deletion of RELMb may reduce
2 and MMP-9 via ERK1/2 andSham 15 2.1 ± 0.5
Si-NC 15 2.1 ± 0.5
Si- RELMb 15 1.4 ± 0.3
(26)
ApoE−/− mice RELMb mRNA and
protein levels
Ang-II Control NR 28 days NR Increased RELMb mRNA and p
AAA NR
D) Animal studies investigating the effect of Peri-aortic adipose tissue on aortic diameter
(27)
C57BL/6J mice Deletion of AT1a in
PVAT
Ang-II AAA 13 28 days 2.5 ± 1.8 Induction of macrophage migra
stimulated wild-type adipocytes
neutralizing antibody. VAT trans
formation in OPN deficient mice








PVAT intact 5 28 days NR PVAT plays important roles in th
to vascular hypo-perfusion. The
removed vascular wall might be
PVAT removed 7
Control 18 3.8 ± 0.5
AAA, Abdominal aortic aneurysm; APN, Adiponectin; ADMSC, Adipose derived MSC; AdAPN, Recombinant adenoviral APN; AdGFP, Recombinant adenovirus green fluorescent protein
1a; BMSC, Bone marrow derived stem cells; CaCl2, Calcium chloride; CD, Clustered differentiation; G-CSF, Granulocyte colony stimulating factor; IL-18r, Interleukin 18 receptor; W
transcription factor; HDL, High density lipoprotein; HF/HF, High-fat diet acclimatization for 20 weeks followed by high-fat diet continuation for another 8 weeks; HF/LF, High-fat diet accli
weeks; I.P., Intraperitoneal; INF, Interferon; IP-10, Interferon gamma-induced protein 10; LOX, Lysyl oxidase; LDL, Low density lipoprotein; LePA, Leptin antagonist; mRNA, Messen
Monocyte chemoattractant protein; MMP, Matrix metalloproteinase; NC, Negative control; NA, Not available; NR, Not reported; OPN, Osteopontin; ob/ob, Obese mice; PLGA, Poly lactic-







Thanigaimani and Golledge Adiposity and Abdominal Aortic Aneurysmthe expression of matrix remodeling enzymes such as matrix
metalloproteinase (MMP) -2 and 9 in the aortic wall. These
results suggest that adiponectin protects against AAA formation
through multiple different mechanisms, of which inhibiting
inflammation plays a key role. Meta-analysis suggested that
adiponectin upregulation did not significantly reduced AAA
diameter (SMD: −3.16 [95% CI: −7.59, 1.28]) (Figure 4). The
findings of the meta-analysis need to be considered in the context
of the limited number of available studies and included animals.
Animal Studies Investigating the Effect of RELMb
on AAA
Two studies including 60 mice in one study and an unreported
number in one study investigated the role of RELMb in AAA
development (25, 26) (Table1C).Both studies used the samemouse
strain (ApoE−/−) and experimental period. Germline deletion of
RELMb resulted in significantly reduced AAA diameter within the
Ang-II infusion model (25). This was associated with reduced
macrophage accumulation and decreased expression of pro-
inflammatory cytokines (monocyte chemoattractant protein 1
and IL6) and MMP2 and 9 in the aortic wall. Further, it has also
been reported that RELMb expression was upregulated within the
aortas ofmicewithAng-II inducedAAAcompared to controls (26).
These limited investigations suggest that RELMb could have a role
in promoting AAA formation via induction of pro-inflammatory
cytokines. Meta-analysis was not possible due to the lack of
available studies.Frontiers in Endocrinology | www.frontiersin.org 5Animal Studies Investigating the Effect of PVAT
on AAA
Two studies reporting the effect of PVAT in AAA development
in 54 animals were identified (27, 28) (Table 1D). In mice
deficient in osteopontin, angiotensin II type 1a (AT1a)
deficiency of PVAT significantly attenuated the size of AAA
developing, macrophage infiltration, and gelatinolytic activity in
the Ang-II model (27). Another study investigated the effect of
AAA development following the removal of PVAT in a hypo-
perfusion induced AAA rat model (28). In this model, the
authors intended to isolate the oxygen supply and induce
hypoxia in the infra-renal aortic region. First, the PVAT was
removed from around the infra-renal aorta to prevent oxygen
supply via the adventitial vasa vasorum (VV). Following this, a
polyurethane catheter was inserted via a small incision in the
infra-renal aorta to separate the lumen blood flow from the aortic
wall, thus isolating the oxygen supply to the aortic wall from the
blood directly. These two steps reduced the oxygen supply and
induced hypoxia in the infra-renal aortic region without affecting
the systemic circulation, promoting AAA formation. It was
reported that 28 days after the removal of the PVAT the
number of CD44+ and CD90+ cells and adipocytes in the
AAA wall was significantly less when PVAT had been
removed. Mice that has PVAT removed were reported to have
significantly smaller AAA diameter than controls (28). Evidence
from other animal studies has suggested that PVAT contributes
to intimal hyperplasia via leptin signaling (29). Samples fromFIGURE 3 | The included studies had contrasting findings most likely due to the varied methods of leptin upregulation. The meta-analysis suggested that overall
upregulation of leptin had no effect on AAA diameter. Ne, Number of animals in experimental group; Nc, Number of animals in control group.FIGURE 4 | Meta-analysis suggested that upregulation of adiponectin had no significant effect on AAA diameter. Ne, Number of animals in experimental group;
Nc, Number of animals in control group.March 2021 | Volume 12 | Article 618434
Thanigaimani and Golledge Adiposity and Abdominal Aortic Aneurysmmouse models of AAA show infiltration by neutrophils,
mast cells, and T-cells and expression of cathepsin K and S
within PVAT which may contribute to AAA development
(30). The exact role of PVAT in AAA development needs
further investigation.
Quality of Prior Animal Studies Investigating
Adipokines and PVAT in AAA
All studies reported an ethics approval statement, AAA model
type and included relevant control groups (Table 2). None of the
studies reported sample size estimates. Two studies reported that
the assessors were blinded during the aortic diameter and/or
adipokine assessments (20, 21). One study reported the
reproducibility of aortic diameter assessment (20). Three
studies did not report aortic diameter following the assessment
period (21, 26, 28). One study did not report either the age or
weight of the animals used in the study (26). One study did not
report the number of animals included in each group (26).
Overall, one (20), eight (19, 21–25, 27, 28), and one (26)
studies were considered to have low, moderate, and high risk
of bias respectively.
Evidence From Human Studies For A Role
Adipokines and PVAT in AAA Pathogenesis
Studies Investigating the Association of Adipokines With
AAA Diagnosis
Five studies were identified studying the association of
circulating adipokines, including DPP-4, leptin, resistin, and
adiponectin, with AAA in 1146 cases compared with 837
control participants (30–34) (Table 3). The design of the
studies included retrospective cohort, case control, and
prospective cohort. Two studies matched cases and controls for
age (33, 34) and sex (32, 34). Three studies reported that controls
were healthy (30, 32, 34).
A case-control study reported that plasma DPP-4 enzyme
activity was significantly increased in both large and small AAA
patients compared to controls and positively correlated with
AAA diameter (32) (Table 3A). However, circulating DPP-4
plasma levels were similar between control and small AAA
participants and significantly lower in people with large AAA
(32). This study suggested that increased DPP-4 activity may
play a role in AAA pathogenesis but larger studies are needed.
Three studies including 1,034 AAA patients and 808 controls
investigated the association of circulating leptin concentrations
with AAA (31, 33, 34) (Table 3B). A cohort sample of 701
patients from the Atherosclerotic Risk in Communities (ARIC)
study suggested that plasma leptin levels were inversely
associated with AAA diagnosis after adjusting for confounders
including age, sex, race, smoking status, pack-years of smoking,
height, hypertension, high and low density lipoproteins (HDL
and LDL), total cholesterol, and peripheral artery disease, but the
study did not report aortic diameter (31). A prospective cohort
study showed that serum levels of leptin were similar in AAA and
control participants after adjusting for age, smoking, body mass
index (BMI), carotid artery stenosis, diabetes, hypertension,
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TABLE 3 | Examples of clinical studies investigating the association of adipokines with AAA.
r Adipokine levels/HR [95% CI]* p value Confounders adjusted for analyses
9.9 ± 9.2 <0.05 None
19.2 ± 8.2
) 30.4 ± 13.9
HR:
0.8 (0.7–1.0)
NR Age, sex, race, smoking status, pack-years of smoking, height,
hypertension, HDL, LDL, TC, and PAD
7.3 (4.7–11.4) 0.19 Age, smoking, BMI, carotid artery stenosis, DM, arterial
hypertension, HDL, LDL, TC, TG, CRP, and statins9.7 (4.9–17.3)
12.6 ± 9.9 <0.01 Age, dyslipidemia, hypertension, smoking, CHD, DM, WHR,
and serum glucose16.5 ± 16.7
9.4 (7.6–12.3) 0.08 Age, smoking, BMI, carotid artery stenosis, DM, arterial
hypertension, HDL, LDL, TC, TG, adiponectin, leptin, CRP, and
statins
12.7 (8.5–16.8)
20.7 ± 10.5 <0.01 Age, dyslipidemia, hypertension, smoking, CHD, DM, WHR,
and serum glucose27.6 ± 12.1
4.2 (2.7–6.4) 0.86 Age, smoking, BMI, carotid artery stenosis, DM, arterial
hypertension, HDL, LDL, TC, TG, leptin, CRP, and statins3.5 (2.1–11.5)
9.9 ± 4.7 <0.01 Age, dyslipidemia, hypertension, smoking, CHD, DM, WHR,
and serum glucose10.8 ± 4.7
97.5 ± 39.4 NR None
27.8 ± 5.4
al; CRP, C reactive protein; cm, Centimeter; DM, Diabetes mellitus; DPP-4, Dipeptidyl peptidase-4; HR, Hazard ratio; HDL, High
ease; RCT, Randomized controlled trial; TC, Total cholesterol; TG, Triglycerides; WHR, Waist to hip ratio; *Adipokine levels were


































Reference Study design Groups Sample size Aortic diamete
A) Studies estimating the association of DPP-4 activity and AAA
(32) Case control study Control 20 NR$
Small AAA 16 3.6 ± 0.7$
Large AAA 77 5.9 ± 1.4$ (cm
B) Studies estimating the association of leptin and AAA
(31)d Retrospective cohort study AAA 701 NR
(33) Prospective cohort study No AAA 174 NR
AAA 15 NR
(34)d Cohort from population based RCT Control 634 19–22# (mm)
AAA 318 ≥30 (mm)
C) Studies estimating the association of Resistin and AAA
(33) Prospective cohort study No AAA 174 NR
AAA 15 NR
(34)d Cohort from population based RCT Control 634 19–22# (mm)
AAA 318 ≥30 (mm)
D) Studies estimating the association of adiponectin and AAA
(33) Prospective cohort study No AAA 174 NR
AAA 15 NR
(34)d Cohort from population based RCT Control 634 19–22# (mm)
AAA 318 ≥30 (mm)
(30)** Case control study Control 9 NR
AAA 19 63.0 ± 12.2$
AAA, Abdominal aortic aneurysm; BMI, Body mass index; CHD, Coronary heart disease; CI, Confidence interv
density lipoprotein; LDL, Low density lipoprotein; NR, Not reported; mm, Millimeter; PAD, Peripheral artery dis
either mentioned as mean ± S.D. or median (25th–75th percentile range); **Adipokine levels data extracted from
diameter measured using Computed tomography (CT).
Thanigaimani and Golledge Adiposity and Abdominal Aortic Aneurysmsuggesting that leptin was not associated with AAA (33).
Another population based study reported leptin levels in 952
men screened for AAA, 318 of whom had an AAA diagnosed.
Results from this study suggested that leptin levels were not
independently associated with AAA after adjusting for
confounders including age, smoking, BMI, carotid artery
stenosis, diabetes, hypertension, HDL, LDL, total cholesterol,
triglycerides, CRP, and statins (34). A meta-analysis suggested
that overall circulating leptin levels were higher in people
diagnosed with an AAA than controls (SMD: 0.32 [95% CI:
0.19, 0.45]) (Figure 5). It was not possible to adjust this meta-
analysis for confounding risk factors.
Two studies including 333 AAA patients and 808 controls
investigated the association of serum resistin levels with AAA
(33, 34) (Table 3C). A prospective cohort study showed a trend
toward higher resistin levels in participants with AAA compared
to controls (33). Multivariate analyses showed that serum resistin
levels were independently associated with AAA after adjusting
for age, smoking, BMI, carotid artery stenosis, diabetes,
hypertension, HDL, LDL, cholesterol , triglycerides,
adiponectin, leptin, CRP, and statin medication (33). A
population-based study in men found that serum resistin
concentrations were independently associated with AAA after
adjusting for age, dyslipidemia, hypertension, smoking, CHD,
and diabetes mellitus, waist-hip ratio, and serum glucose (34).
Meta-analysis of these studies suggested that serum resistin levels
were significantly higher in people diagnosed with AAA
compared to controls (SMD: 0.63 [95% CI 0.50, 0.76])
(Figure 6).
Three studies including 352 AAA patients and 817 controls
investigated the association of circulating adiponectin with AAAFrontiers in Endocrinology | www.frontiersin.org 8(30, 33, 34) (Table 3D). A prospective cohort study showed no
independent association of serum levels of adiponectin with
AAA after adjusting for age, smoking, BMI, carotid artery
stenosis, diabetes, hypertension, lipids, CRP, and statin
prescription (33). A population-based study found that serum
levels of adiponectin were associated with AAA ≥30 mm, but not
AAA ≥40 mm, suggesting that adiponectin may play a role in the
early stages of AAA development (34). A case-control study
reported that serum levels of adiponectin were significantly lower
in AAA patients compared to healthy control organ donors,
however, adiponectin was significantly increased in PVAT
surrounding the AAA, suggesting that adipocytes surrounding
the aorta may be a source of inflammatory leukocytes that are
attracted by adipocytes undergoing necrosis and by pro-
inflammatory ceramides (30). Meta-analysis suggested that
serum adiponectin levels were not significantly associated with
AAA diagnosis (SMD: −0.62 [95% CI −1.76, 0.52]) (Figure 7).
Phenotypic changes in PVAT resulting from vascular injury have
been reported to promote neointimal formation via release of
adipocytokines which in turn regulate inflammation, vascular
smooth muscle cell proliferation, endothelial dysfunction,
fibroblast activation and migration and neovascularization
(35). Furthermore, high fat diet or smoking have also been
suggested to promote vascular inflammation, reactive oxygen
species production, and matrix degradation that augments AAA
formation (36).
Quality of Human Studies Investigating the Association of
Adipokines With AAA
All studies measured adipokines in AAA cases and a comparator
group (Table 3) (30–34). Three studies reported the results afterFIGURE 5 | Forest plot suggesting the association of high circulating leptin concentrations with AAA diagnosis. Ne, Number of patients in experimental group; Nc,
Number of patients in control group.FIGURE 6 | Forest plot suggesting the association of high circulating resistin concentrations with AAA diagnosis. Ne, Number of patients in experimental group; Nc,
Number of patients in control group.March 2021 | Volume 12 | Article 618434
Thanigaimani and Golledge Adiposity and Abdominal Aortic Aneurysmadjusting for confounders (31, 33, 34). Three studies reported the
methods used for aortic diameter imaging (30, 32, 34). Two studies
reported the methods used for aortic diameter assessment (32, 34).
One study imaged both AAA cases and the comparator groups
(34). One study reported the sample size estimates used (31).
Studies Examining the Association of PVAT With AAA
Three studies were identified investigating peri-aortic and
visceral adipose tissue in 3,337 AAA cases compared with 382
control participants (37–39) (Table 4). The design of the studies
included retrospective, prospective, and longitudinal cohort and
case-control studies. All three studies matched the AAA cases
and comparators for age and sex (37–39). In a multicenter
retrospective case-control study, comparison of participants
with asymptomatic AAA, aortoiliac occlusive disease (AIOD),
and healthy controls suggested that AAA was associated with
higher PVAT density and the visceral to subcutaneous adipose
tissue (VAT/SAT) ratio was significantly greater in AAA patients
(37). This association persisted after adjustment for
cardiovascular risk factors and other diseases. Another case-
control study compared AAA and intermittent claudication
control subjects and also reported that the visceral to total
abdominal adipose volume ratio was significantly greater in
participants diagnosed with AAA, but the association wasFrontiers in Endocrinology | www.frontiersin.org 9abolished after adjusted for age, heart disease, diabetes,
smoking, sex, and hypertension (38). In a Framingham study
including 3,001 individuals, the authors reported a significant
association between peri-aortic fat deposition and larger aortic
dimensions after adjusting for age, sex, cardiometabolic risk
factors, and BMI, further supporting the notion that fat depots
present around the aorta may contribute to its remodeling (39).
Meta-analysis suggested that PVAT to abdominal adipose tissue
ratio was significantly associated with AAA diagnosis (SMD: 0.56
[95% CI 0.33, 0.79]) (Figure 8).
Quality of Human Studies Investigating
the Association of PVAT With AAA
All studies reported the methods used to image the aorta, methods
used for aortic diameter assessment and adjusted for potential
confounders during analysis (Table 4) (37–39). Two studies
reported the sample size estimate used (37, 38). Only one study
blinded the observer during analysis of experimental data (37).
Overall Quality Assessment of All Included
Human Studies
Overall, two (37, 38), two (34, 39), and four (30–33) of the
clinical research studies were considered to have low, moderate,
and high risk of bias respectively (Table 5).FIGURE 7 | Forest plot suggesting no association of circulating adiponectin concentrations with AAA diagnosis. Ne, Number of patients in experimental group;
Nc, Number of patients in control group.TABLE 4 | Examples of clinical studies investigating the association of perivascular adipose tissue with AAA.
Reference Study design Groups Sample
size
Aortic diameter PVAT to AAT ratio p
value




Control 97 2.0 ± 0.2$ (cm) 1.2 ± 0.7* 0.006 Gender, diabetes, hypertension, smoking, CHD,
PAD, BMI, anticoagulation, antiplatelet therapy,
vasodilator, diuretics, CCB, BB, statins
AIOD 104 2.1 ± 0.4$ (cm) 1.2 ± 0.8*
aAAA 140 6.1 ± 1.4$ (cm) 1.5 ± 0.7*
(38) Case control
study
AAA 196 50.0 (42.0–57.0)$ (mm) 0.5 (0.4, 0.6)** 0.007 Age, CHD, diabetes, ever smoked, sex and







1,474 17 ± 2$ (mm) HR (95% CI):
VAT - 0.3 (0.2 to 0.4)d
AAT - 0.3 (0.2 to 0.3)d
<0.01 Age, sex, cardiometabolic risk factors, and BMI
AAA in
men
1,527 19 ± 2$ (mm)AAA, Abdominal aortic aneurysm; aAAA, Asymptomatic AAA; AAT, Abdominal peri-aortic fat; AIOD, Aortoiliac occlusive disease; BB, Beta blockers; BMI, Body mass index; CCB, Calcium
channel blockers; CHD, Coronary heart disease; CI, Confidence interval; cm, Centimeter; HR, Hazard ratio; IC, Intermittent claudication; mm, Millimeter; PAD, Peripheral artery disease;
PVAT, Perivascular adipose tissue; VAT/SAT, Visceral adipose tissue/subcutaneous adipose tissue; *Data reported as mean ± Standard deviation; **Data reported as median with 25th and
75th percentile range; ᵟ, Data reported as hazard ratio with 95% confidence interval; $Aortic diameter measured using Computed tomography (CT).March 2021 | Volume 12 | Article 618434
Thanigaimani and Golledge Adiposity and Abdominal Aortic AneurysmCONCLUSIONS
Overall this systematic review suggests inconsistent effects of
adipokines and PVAT on AAA development within rodent AAA
models. Circulating levels of leptin and resistin and PVAT to
abdominal adipose tissue ratio, but not adiponectin, were found
to be significantly greater in people diagnosed with AAA
compared to controls. Given the limited number of eligible
animal and human studies, more evidence is needed before
any robust conclusions about the role of adipokines and PVAT
in AAA pathogenesis can be made. The quality assessments
suggested that this past research had a moderate risk of bias.DATA AVAILABILITY STATEMENT
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